Factors That Influence Response to ASHAP
. | CR . | PR . | Failure . | Chi Square for Independence . |
---|---|---|---|---|
Extranodal sites | ||||
0 | 12 | 7 | 7 | |
1 | 6 | 7 | 6 | 0.28 |
≥2 | 1 | 6 | 4 | |
Response duration (months) to last treatment | ||||
<12 | 10 | 14 | 9 | |
≥12 | 9 | 6 | 8 | 0.45 |
<6 | 8 | 10 | 14 | |
≥6 | 11 | 10 | 3 | 0.01 |
Radiotherapy | ||||
Yes | 8 | 9 | 12 | |
No | 11 | 11 | 5 | 0.09 |
Stage at relapse | ||||
Localized | 7 | 6 | 6 | 0.72 |
Disseminated | 12 | 14 | 11 | |
B symptoms | ||||
No | 15 | 12 | 8 | |
Yes | 4 | 8 | 9 | 0.04 |
. | CR . | PR . | Failure . | Chi Square for Independence . |
---|---|---|---|---|
Extranodal sites | ||||
0 | 12 | 7 | 7 | |
1 | 6 | 7 | 6 | 0.28 |
≥2 | 1 | 6 | 4 | |
Response duration (months) to last treatment | ||||
<12 | 10 | 14 | 9 | |
≥12 | 9 | 6 | 8 | 0.45 |
<6 | 8 | 10 | 14 | |
≥6 | 11 | 10 | 3 | 0.01 |
Radiotherapy | ||||
Yes | 8 | 9 | 12 | |
No | 11 | 11 | 5 | 0.09 |
Stage at relapse | ||||
Localized | 7 | 6 | 6 | 0.72 |
Disseminated | 12 | 14 | 11 | |
B symptoms | ||||
No | 15 | 12 | 8 | |
Yes | 4 | 8 | 9 | 0.04 |